This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Oxalurx, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Thomas Leedom: Innovator in Oxalate-Related Disease Treatment
Introduction
Thomas Leedom is a notable inventor based in Escondido, California. He has made significant contributions to the field of medical treatments, particularly in addressing oxalate-related diseases. His innovative work has the potential to improve the lives of many patients suffering from these conditions.
Latest Patents
Thomas Leedom holds a patent for "Compounds and methods for treating oxalate-related diseases." This patent discloses compounds and compositions for modulating glycolate oxidase, which is useful for treating conditions such as hyperoxaluria. The methods outlined in the patent aim to modulate glycolate oxidase activity in human or animal subjects, providing therapeutic benefits to those in need.
Career Highlights
Leedom's career is marked by his dedication to research and development in the medical field. He is currently associated with Oxalurx, Inc., where he continues to work on innovative solutions for treating oxalate-related diseases. His expertise and commitment to advancing medical science are evident in his patent and ongoing research efforts.
Collaborations
Thomas Leedom collaborates with talented professionals in his field, including Ayman Kabakibi and Mehmet Kahraman. These partnerships enhance the research and development process, fostering innovation and the potential for groundbreaking treatments.
Conclusion
Thomas Leedom's contributions to the treatment of oxalate-related diseases through his patent and work at Oxalurx, Inc. highlight his role as an important inventor in the medical field. His innovative approaches have the potential to make a significant impact on patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile